Skip to main content
. 2017 Sep 15;96(37):e8006. doi: 10.1097/MD.0000000000008006

Figure 2.

Figure 2

Kaplan–Meier survival curves for estimating the probability of (A) progression-free survival and (B) overall survival after treatment with secondary cytoreductive surgery plus chemotherapy (N = 29) versus chemotherapy alone (N = 29) in a propensity score-matched cohort.